SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-039494
Filing Date
2019-11-04
Accepted
2019-11-04 06:07:26
Documents
11
Period of Report
2019-10-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K insy-8k_20191031.htm 8-K 50639
2 EX-2.1 insy-ex21_6.htm EX-2.1 76394
3 EX-99.1 insy-ex991_7.htm EX-99.1 122638
4 GRAPHIC gra4jngpnigy000001.jpg GRAPHIC 10404
5 GRAPHIC gra4jngpnigy000002.jpg GRAPHIC 80690
6 GRAPHIC gra4jngpnigy000005.jpg GRAPHIC 53498
7 GRAPHIC gra4jngpnigy000008.jpg GRAPHIC 17207
8 GRAPHIC gra4jngpnigy000007.jpg GRAPHIC 12159
9 GRAPHIC gra4jngpnigy000006.jpg GRAPHIC 100010
10 GRAPHIC gra4jngpnigy000004.jpg GRAPHIC 30887
11 GRAPHIC gra4jngpnigy000003.jpg GRAPHIC 60132
  Complete submission text file 0001564590-19-039494.txt   754741
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Filer) CIK: 0001516479 (see all company filings)

IRS No.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35902 | Film No.: 191188181
SIC: 2834 Pharmaceutical Preparations